Advertisement

Ads Placeholder
Loading...

GRAIL, Inc.

GRALNASDAQ
Healthcare
Medical - Diagnostics & Research
$54.99
$1.39(2.59%)
U.S. Market opens in 19h 19m

GRAIL, Inc. (GRAL) Stock Overview

Explore GRAIL, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.3B
P/E Ratio-5.48
EPS (TTM)$-11.11
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$43.63
3 Months$95.95
1 Year Target$128.10

GRAL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GRAIL, Inc. (GRAL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $128.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.48 and a market capitalization of 2.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.59%
5-Day Change
7.82%
1-Month Change
4.23%
3-Month Change
-38.12%
6-Month Change
-16.11%
Year-to-Date (YTD) Change
-38.12%
1-Year Change
121.02%
3-Year Change
302.56%
5-Year Change
302.56%
All-Time (Max) Change
302.56%

Contact Information

833-694-2553
1525 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

10,000 Employees
IPO DateJun 12, 2024
CountryUS
Actively Trading

Frequently Asked Questions